Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: An imbalance of angiogenesis-associated factors may predispose to preeclampsia. Here, we determined the ratio of serum concentration of soluble fms-like tyrosine kinase 1 (sFlt-1), a natural inhibitor of pro-angiogenic vascular endothelial growth factor (VEGF) relative to angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of VEGF, in women with preeclampsia. Methods: The levels of serum sFlt-1 and Ang-2 were measured by enzyme-linked immunosorbent assay. Results: Significant decrease of serum Ang-2 and the increase of sFlt-1 were observed in women with preeclampsia as compared to healthy pregnant women. The serum sFlt-1/Ang-2 ratio was strikingly increased in preeclamptic women in contrast to healthy pregnant women exhibiting lower value similar to non-pregnant women. The serum sFlt-1 concentrations tended to positively correlate with mean blood pressure (BP) in preeclamptic women, but not in healthy pregnant women. A cut-off value >0.25 in the serum sFlt-1/Ang-2 ratio showed 87.1% sensitivity and 82.8% specificity in differentiating preeclamptic women from healthy pregnant women. Conclusion: The serum sFlt-1/Ang-2 ratio is significantly elevated in preeclamptic women as compared to healthy pregnant women. Remarkable difference of sFlt-1/Ang-2 ratio between these two groups with excellent specificity and sensitivity suggests the clinical usefulness of the serum sFlt-1/Ang-2 ratio in diagnosing and potentially predicting the onset of preeclampsia.

Original languageEnglish
JournalNephron - Clinical Practice
Volume106
Issue number1
DOIs
Publication statusPublished - May 2007

Fingerprint

Angiopoietin-2
Vascular Endothelial Growth Factor Receptor-1
Pre-Eclampsia
Serum
Pregnant Women
Vascular Endothelial Growth Factor A
Angiopoietin-1
Sensitivity and Specificity
Angiogenesis Inhibitors
Angiogenesis Inducing Agents
Enzyme-Linked Immunosorbent Assay
Blood Pressure

Keywords

  • Angiogenesis
  • Angiopoietin-2
  • Preeclampsia
  • sFlt-1
  • sFlt-1/Ang-2 ratio

ASJC Scopus subject areas

  • Nephrology

Cite this

Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia. / Hirokoshi, Kumiko; Maeshima, Yohei; Kobayashi, Kazuko; Matsuura, Eiji; Sugiyama, Hitoshi; Yamasaki, Yasushi; Masuyama, Hisashi; Hiramatsu, Yuji; Makino, Hirofumi.

In: Nephron - Clinical Practice, Vol. 106, No. 1, 05.2007.

Research output: Contribution to journalArticle

@article{c5a7ba015ba74c72af6a3265b91d80d9,
title = "Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia",
abstract = "Background: An imbalance of angiogenesis-associated factors may predispose to preeclampsia. Here, we determined the ratio of serum concentration of soluble fms-like tyrosine kinase 1 (sFlt-1), a natural inhibitor of pro-angiogenic vascular endothelial growth factor (VEGF) relative to angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of VEGF, in women with preeclampsia. Methods: The levels of serum sFlt-1 and Ang-2 were measured by enzyme-linked immunosorbent assay. Results: Significant decrease of serum Ang-2 and the increase of sFlt-1 were observed in women with preeclampsia as compared to healthy pregnant women. The serum sFlt-1/Ang-2 ratio was strikingly increased in preeclamptic women in contrast to healthy pregnant women exhibiting lower value similar to non-pregnant women. The serum sFlt-1 concentrations tended to positively correlate with mean blood pressure (BP) in preeclamptic women, but not in healthy pregnant women. A cut-off value >0.25 in the serum sFlt-1/Ang-2 ratio showed 87.1{\%} sensitivity and 82.8{\%} specificity in differentiating preeclamptic women from healthy pregnant women. Conclusion: The serum sFlt-1/Ang-2 ratio is significantly elevated in preeclamptic women as compared to healthy pregnant women. Remarkable difference of sFlt-1/Ang-2 ratio between these two groups with excellent specificity and sensitivity suggests the clinical usefulness of the serum sFlt-1/Ang-2 ratio in diagnosing and potentially predicting the onset of preeclampsia.",
keywords = "Angiogenesis, Angiopoietin-2, Preeclampsia, sFlt-1, sFlt-1/Ang-2 ratio",
author = "Kumiko Hirokoshi and Yohei Maeshima and Kazuko Kobayashi and Eiji Matsuura and Hitoshi Sugiyama and Yasushi Yamasaki and Hisashi Masuyama and Yuji Hiramatsu and Hirofumi Makino",
year = "2007",
month = "5",
doi = "10.1159/000101483",
language = "English",
volume = "106",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia

AU - Hirokoshi, Kumiko

AU - Maeshima, Yohei

AU - Kobayashi, Kazuko

AU - Matsuura, Eiji

AU - Sugiyama, Hitoshi

AU - Yamasaki, Yasushi

AU - Masuyama, Hisashi

AU - Hiramatsu, Yuji

AU - Makino, Hirofumi

PY - 2007/5

Y1 - 2007/5

N2 - Background: An imbalance of angiogenesis-associated factors may predispose to preeclampsia. Here, we determined the ratio of serum concentration of soluble fms-like tyrosine kinase 1 (sFlt-1), a natural inhibitor of pro-angiogenic vascular endothelial growth factor (VEGF) relative to angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of VEGF, in women with preeclampsia. Methods: The levels of serum sFlt-1 and Ang-2 were measured by enzyme-linked immunosorbent assay. Results: Significant decrease of serum Ang-2 and the increase of sFlt-1 were observed in women with preeclampsia as compared to healthy pregnant women. The serum sFlt-1/Ang-2 ratio was strikingly increased in preeclamptic women in contrast to healthy pregnant women exhibiting lower value similar to non-pregnant women. The serum sFlt-1 concentrations tended to positively correlate with mean blood pressure (BP) in preeclamptic women, but not in healthy pregnant women. A cut-off value >0.25 in the serum sFlt-1/Ang-2 ratio showed 87.1% sensitivity and 82.8% specificity in differentiating preeclamptic women from healthy pregnant women. Conclusion: The serum sFlt-1/Ang-2 ratio is significantly elevated in preeclamptic women as compared to healthy pregnant women. Remarkable difference of sFlt-1/Ang-2 ratio between these two groups with excellent specificity and sensitivity suggests the clinical usefulness of the serum sFlt-1/Ang-2 ratio in diagnosing and potentially predicting the onset of preeclampsia.

AB - Background: An imbalance of angiogenesis-associated factors may predispose to preeclampsia. Here, we determined the ratio of serum concentration of soluble fms-like tyrosine kinase 1 (sFlt-1), a natural inhibitor of pro-angiogenic vascular endothelial growth factor (VEGF) relative to angiopoietin-2 (Ang-2), a natural antagonist of angiopoietin-1 (Ang-1) involved in promoting angiogenesis in the presence of VEGF, in women with preeclampsia. Methods: The levels of serum sFlt-1 and Ang-2 were measured by enzyme-linked immunosorbent assay. Results: Significant decrease of serum Ang-2 and the increase of sFlt-1 were observed in women with preeclampsia as compared to healthy pregnant women. The serum sFlt-1/Ang-2 ratio was strikingly increased in preeclamptic women in contrast to healthy pregnant women exhibiting lower value similar to non-pregnant women. The serum sFlt-1 concentrations tended to positively correlate with mean blood pressure (BP) in preeclamptic women, but not in healthy pregnant women. A cut-off value >0.25 in the serum sFlt-1/Ang-2 ratio showed 87.1% sensitivity and 82.8% specificity in differentiating preeclamptic women from healthy pregnant women. Conclusion: The serum sFlt-1/Ang-2 ratio is significantly elevated in preeclamptic women as compared to healthy pregnant women. Remarkable difference of sFlt-1/Ang-2 ratio between these two groups with excellent specificity and sensitivity suggests the clinical usefulness of the serum sFlt-1/Ang-2 ratio in diagnosing and potentially predicting the onset of preeclampsia.

KW - Angiogenesis

KW - Angiopoietin-2

KW - Preeclampsia

KW - sFlt-1

KW - sFlt-1/Ang-2 ratio

UR - http://www.scopus.com/inward/record.url?scp=34247898962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247898962&partnerID=8YFLogxK

U2 - 10.1159/000101483

DO - 10.1159/000101483

M3 - Article

C2 - 17409768

AN - SCOPUS:34247898962

VL - 106

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 1

ER -